Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
<p>Abstract</p> <p>Background</p> <p>The clinical effects of mucolytics in patients with chronic obstructive pulmonary disease (COPD) are discussed controversially. Cineole is the main constituent of eucalyptus oil and mainly used in inflammatory airway diseases as a mu...
Main Authors: | Schacher Christian, Worth Heinrich, Dethlefsen Uwe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/10/1/69 |
Similar Items
-
1,8-cineole (eucalyptol): A versatile phytochemical with therapeutic applications across multiple diseases
by: Cosima C. Hoch, et al.
Published: (2023-11-01) -
Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
by: Fukuchi Y, et al.
Published: (2016-04-01) -
Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation
by: Balaji Venkataraman, et al.
Published: (2023-03-01) -
1,8-Cineol (Eucalyptol) Disrupts Membrane Integrity and Induces Oxidative Stress in Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Abderrahmen Merghni, et al.
Published: (2023-07-01) -
In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
by: Heinrich Worth, et al.
Published: (2023-01-01)